Antitumor Effect of Low-Dose of Rapamycin in a Transgenic Mouse Model of Liver Cancer
Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma
YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation
c-myc-driven hepatocarcinogenesis
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
Mapk/erk signaling pathway in hepatocellular carcinoma
Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway